SPRITAM is manufactured with US-sourced levetiracetam by Aprecia Pharmaceuticals, LLC in Blue Ash, Ohio USA. The manufacturing facility is the first and only in the world to receive FDA authorization to produce a three-dimensionally printed pharmaceutical product for commercial sale in the United States.

Terms & Conditions
Try Spritam for as little as $10

For patients with certain types of epilepsy, who may struggle to swallow medicine —

What kind of seizures can be treated with SPRITAM?

SPRITAM (levetiracetam) is a prescription medicine taken by mouth that is used to treat partial-onset seizures in people 4 years of age and older. SPRITAM is also used with other medicines to treat myoclonic seizures in people 12 years of age and older with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in people 6 years of age and older with certain types of generalized epilepsy. SPRITAM is recommended for use in people weighing more than 20 kg (44 lbs).

Easy to Take.

SPRITAM is an advanced fast-melt tablet
designed for ease of swallowing with just a
sip of water.


SPRITAM provides the safety profile
and seizure reduction of

† SPRITAM is the first and only 3D-printed (3DP) medicine. 3DP enables significantly higher drug loading than traditional fast-melt dosage forms. SPRITAM disintegrates in a mean time of 11 seconds (range of 2 to 27 seconds).
‡ Based on comparable rate and extent of absorption to conventional immediate-release (IR) levetiracetam tablets.

Is SPRITAM right for you or someone you care for?

Your experience matters. Answer a few simple questions and talk to your healthcare provider to find out if SPRITAM may be an appropriate treatment.

Made using 3D printing

Aprecia’s proprietary technology combines 3D printing and formulation science to produce rapidly disintegrating oral medicines.

Save on your prescription for SPRITAM

You may be able to lower your out-of-pocket costs for SPRITAM.